The multinational company is accused of failing to market a device developed by the UK Ministry of Defence for diagnosing infections of the superbug, going against the terms agreed when 3M acquired the device
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.